| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2020 ( Subtotal = -$150,636 ) |
| | 2020 | 2017 | METABOLIC TECHNOLOGIES, INC. | 2711 S LOOP DR STE 4400 | AMES | IA | 50010-8656 | STORY | USA | R44AG055184 | 2-Hydroxybenzylamine for the prevention of Alzheimer's disease: Initial evaluation in humans | 001 | 2 | NIH | 11/6/2019 | $0 |
| | 2020 | 2017 | METABOLIC TECHNOLOGIES, INC. | 2711 S LOOP DR STE 4400 | AMES | IA | 50010-8656 | STORY | USA | R44AG055184 | 2-Hydroxybenzylamine for the prevention of Alzheimer's disease: Initial evaluation in humans | 002 | 2 | NIH | 11/15/2019 | $0 |
| | 2020 | 2017 | METABOLIC TECHNOLOGIES, INC. | 2711 S LOOP DR STE 4400 | AMES | IA | 50010-8656 | STORY | USA | R44AG055184 | 2-Hydroxybenzylamine for the prevention of Alzheimer's disease: Initial evaluation in humans | 003 | 2 | NIH | 11/15/2019 | -$150,636 |
| | 2020 | 2016 | METABOLIC TECHNOLOGIES, INC. | 2711 S LOOP DR STE 4400 | AMES | IA | 50010-8656 | STORY | USA | R44AG055184 | 2-Hydroxybenzylamine for the prevention of Alzheimer's disease: Initial evaluation in humans | 000 | 1 | NIH | 11/5/2019 | $0 |
| | 2020 | 2016 | METABOLIC TECHNOLOGIES, INC. | 2711 S LOOP DR STE 4400 | AMES | IA | 50010-8656 | STORY | USA | R44AG034722 | Nutritional Intervention for Age-Related Muscular Function and Strength Losses | 000 | 3 | NIH | 4/24/2020 | $0 |
|
| Issue Date FY: 2019 ( Subtotal = -$605,216 ) |
| | 2019 | 2017 | METABOLIC TECHNOLOGIES, INC. | 2711 S LOOP DR STE 4400 | AMES | IA | 50010-8656 | STORY | USA | R44AG055184 | 2-Hydroxybenzylamine for the prevention of Alzheimer's disease: Initial evaluation in humans | 000 | 2 | NIH | 7/6/2019 | -$605,216 |
| | 2019 | 2017 | METABOLIC TECHNOLOGIES, INC. | 2711 S LOOP DR STE 4400 | AMES | IA | 50010-8656 | STORY | USA | R44AG055184 | 2-Hydroxybenzylamine for the prevention of Alzheimer's disease: Initial evaluation in humans | 001 | 2 | NIH | 7/7/2019 | $0 |
|
| Issue Date FY: 2018 ( Subtotal = $0 ) |
| | 2018 | 2017 | METABOLIC TECHNOLOGIES, INC. | 2711 S LOOP DR STE 4400 | AMES | IA | 50010-8656 | STORY | USA | R44AG034722 | Nutritional Intervention for Age-Related Muscular Function and Strength Losses | 001 | 3 | NIH | 3/12/2018 | $0 |
| | 2018 | 2016 | METABOLIC TECHNOLOGIES, INC. | 2711 S LOOP DR STE 4400 | AMES | IA | 50010-8656 | STORY | USA | R44AG034722 | Nutritional Intervention for Age-Related Muscular Function and Strength Losses | 000 | 3 | NIH | 3/12/2018 | $0 |
|
| Issue Date FY: 2017 ( Subtotal = $932,018 ) |
| | 2017 | 2017 | METABOLIC TECHNOLOGIES, INC. | 2711 S LOOP DR STE 4400 | AMES | IA | 50010-8656 | STORY | USA | R44AG034722 | Nutritional Intervention for Age-Related Muscular Function and Strength Losses | 000 | 3 | NIH | 7/5/2017 | $97,745 |
| | 2017 | 2017 | METABOLIC TECHNOLOGIES, INC. | 2711 S LOOP DR STE 4400 | AMES | IA | 50010-8656 | STORY | USA | R44AG055184 | 2-Hydroxybenzylamine for the prevention of Alzheimer's disease: Initial evaluation in humans | 001 | 2 | NIH | 9/22/2017 | $150,636 |
| | 2017 | 2017 | METABOLIC TECHNOLOGIES, INC. | 2711 S LOOP DR STE 4400 | AMES | IA | 50010-8656 | STORY | USA | R44AG055184 | 2-Hydroxybenzylamine for the prevention of Alzheimer's disease: Initial evaluation in humans | 000 | 2 | NIH | 6/21/2017 | $683,637 |
|
| Issue Date FY: 2016 ( Subtotal = $1,047,478 ) |
| | 2016 | 2016 | METABOLIC TECHNOLOGIES, INC | 2625 NORTH LOOP DR, STE 2150 | AMES | IA | 50010 | STORY | USA | R44AG055184 | 2-Hydroxybenzylamine for the prevention of Alzheimer's disease: Initial evaluation in humans | 000 | 1 | NIH | 9/22/2016 | $672,479 |
| | 2016 | 2016 | METABOLIC TECHNOLOGIES, INC | 2625 NORTH LOOP DR, STE 2150 | AMES | IA | 50010 | STORY | USA | R44AG034722 | Nutritional Intervention for Age-Related Muscular Function and Strength Losses | 000 | 3 | NIH | 2/29/2016 | $374,999 |
|
| Issue Date FY: 2015 ( Subtotal = $0 ) |
| | 2015 | 2014 | METABOLIC TECHNOLOGIES, INC | 2625 NORTH LOOP DR, STE 2150 | AMES | IA | 50010 | STORY | USA | R44AG034722 | Nutritional Intervention for Age-Related Muscular Function and Strength Losses | 000 | 2 | NIH | 3/5/2015 | $0 |
|
| Issue Date FY: 2014 ( Subtotal = $526,586 ) |
| | 2014 | 2014 | METABOLIC TECHNOLOGIES, INC | 2625 NORTH LOOP DR, STE 2150 | AMES | IA | 50010 | STORY | USA | R43AA023715 | Gamma-ketoaldehyde scavengers for alcoholic liver disease | 000 | 1 | NIH | 9/24/2014 | $151,587 |
| | 2014 | 2014 | METABOLIC TECHNOLOGIES, INC | 2625 NORTH LOOP DR, STE 2150 | AMES | IA | 50010 | STORY | USA | R44AG034722 | Nutritional Intervention for Age-Related Muscular Function and Strength Losses | 000 | 2 | NIH | 3/12/2014 | $374,999 |
|
| Issue Date FY: 2013 ( Subtotal = $0 ) |
| | 2013 | 2010 | METABOLIC TECHNOLOGIES, INC | 2625 NORTH LOOP DR, STE 2150 | AMES | IA | 50010 | STORY | USA | R44AG034722 | Nutritional Intervention for Age-Related Muscular Function and Strength Losses | 000 | 1 | NIH | 2/21/2013 | $0 |
|
| Issue Date FY: 2012 ( Subtotal = $0 ) |
| | 2012 | 2010 | METABOLIC TECHNOLOGIES, INC | 2625 NORTH LOOP DR, STE 2150 | AMES | IA | 50010 | STORY | USA | R44AG034722 | Nutritional Intervention for Age-Related Muscular Function and Strength Losses | 000 | 1 | NIH | 4/5/2012 | $0 |
|
| Issue Date FY: 2010 ( Subtotal = $100,000 ) |
| | 2010 | 2010 | METABOLIC TECHNOLOGIES, INC | 2625 NORTH LOOP DR, STE 2150 | AMES | IA | 50010 | STORY | USA | R44AG034722 | Nutritional Intervention for Age-Related Muscular Function and Strength Losses | 000 | 1 | NIH | 3/11/2010 | $100,000 |
|
| Issue Date FY: 2005 ( Subtotal = $363,674 ) |
| | 2005 | 2005 | METABOLIC TECHNOLOGIES, INC | 2625 NORTH LOOP DR, STE 2150 | AMES | IA | 50010 | STORY | USA | R44AG020897 | NUTRITIONAL INTERVENTION FOR OLDER ADULT MUSCLE LOSS | 000 | 3 | NIH | 8/8/2005 | $363,674 |
|
| Issue Date FY: 2004 ( Subtotal = $379,424 ) |
| | 2004 | 2004 | METABOLIC TECHNOLOGIES, INC | 2625 NORTH LOOP DR, STE 2150 | AMES | IA | 50010 | STORY | USA | R44AG020897 | NUTRITIONAL INTERVENTION FOR OLDER ADULT MUSCLE LOSS | 000 | 2 | NIH | 7/6/2004 | $379,424 |
|
| Issue Date FY: 2003 ( Subtotal = $199,991 ) |
| | 2003 | 2003 | METABOLIC TECHNOLOGIES, INC | 2625 NORTH LOOP DR, STE 2150 | AMES | IA | 50010 | STORY | USA | R43DK061818 | ADJUVANT NUTRITION FOR CRITICALLY III TRAUMA PATIENTS | 000 | 1 | NIH | | $99,990 |
| | 2003 | 2003 | METABOLIC TECHNOLOGIES, INC | 2625 NORTH LOOP DR, STE 2150 | AMES | IA | 50010 | STORY | USA | R44AG020897 | NUTRITIONAL INTERVENTION FOR OLDER ADULT MUSCLE LOSS | 000 | 1 | NIH | 7/30/2003 | $100,001 |
|
| Issue Date FY: 2002 ( Subtotal = $367,314 ) |
| | 2002 | 2002 | METABOLIC TECHNOLOGIES, INC | 2625 NORTH LOOP DR, STE 2150 | AMES | IA | 50010 | STORY | USA | R44CA083443 | NUTRITIONAL INTERVENTION FOR CANCER CACHEXIA | 000 | 3 | NIH | 3/12/2002 | $367,314 |
|
| Issue Date FY: 2001 ( Subtotal = $386,951 ) |
| | 2001 | 2001 | METABOLIC TECHNOLOGIES, INC | 2625 NORTH LOOP DR, STE 2150 | AMES | IA | 50010 | STORY | USA | R44CA083443 | NUTRITIONAL INTERVENTION FOR CANCER CACHEXIA | 000 | 2 | NIH | 3/8/2001 | $386,951 |
|
| Issue Date FY: 2000 ( Subtotal = $98,900 ) |
| | 2000 | 2000 | METABOLIC TECHNOLOGIES, INC | 2625 NORTH LOOP DR, STE 2150 | AMES | IA | 50010 | STORY | USA | R43AI046877 | BODY PROTEIN METABOLISM AND NUTRITION IN AIDS-WASTING | 000 | 1 | NIH | 9/27/2000 | $98,900 |
|
| Issue Date FY: 1999 ( Subtotal = $100,000 ) |
| | 1999 | 1999 | METABOLIC TECHNOLOGIES, INC | 2625 NORTH LOOP DR, STE 2150 | AMES | IA | 50010 | STORY | USA | R43CA083443 | NUTRITIONAL INTERVENTION FOR CANCER CACHEXIA | 000 | 1 | NIH | 7/30/1999 | $100,000 |
|
| Issue Date FY: 1997 ( Subtotal = $100,000 ) |
| | 1997 | | METABOLIC TECHNOLOGIES, INC | 2501 N LOOP DR, STE 300 | AMES | IA | 50010 | STORY | USA | R41AR43020 | 3-METHYLHISTIDINE KINETICS--AN INDICATOR OF MUSCLE MASS | 000 | 01 | NIH | 9/30/1997 | $100,000 |
|
|
